Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Biotechnology
- Agriculture
- Forestry and Fishing
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 28223
Technology is the use of our GENEWARE technology for development of functional genomics in selected agricultural and industrial chemical categories.
The GENEWARE(R) system, a viral-based gene expression technology in plants, that enables the discovery, development and production of new biopharmaceuticals and gene-based agricultural products.
'Alliance Gene' means any nucleotide sequence or fragment thereof that encodes for a Trait in plants, either alone or in conjunction with other encoding sequences, and including antisense or co-suppression use thereof, which is discovered, designed, selected, identified or modified in the course of the Research Collaboration.
Nicotiana Field means all uses of Nicotiana plants, plant cells, seeds or seedlings in the Pharmaceutical Field or as a production host. Nicotiana Field shall not include use of Nicotiana for cigarettes, cigars, pipe tobacco, chewing tobacco and snuff, and seeds/seedlings for the production thereof.
Pharmaceutical Field means all uses and all biological materials and chemical compounds active for the treatment, mitigation, diagnosis or prevention of disease states and conditions in humans and animals; provided, however, that the Pharmaceutical Field shall include active material and compounds for animal uses only which are (i) Products that are subject to registration under FDA or USDA regulations in effect as of the Effective Date for the country in which a particular Product is offered for sale, as interpreted by administrative and judicial decisions, whenever made, and (ii) antimicrobial peptide products; and provided, further, that the Pharmaceutical Field.
IPSCIO Record ID: 367288
From the Effective Date, Licensee is entitled to grant written sublicenses under the Licensed Patents and Licensed Know-How as licensed under this Agreement, solely in Brassica, to its Affiliates and any third party.
Brassica cells, plants, seeds, part of plants of any species of the genus Brassica cultivated for oilseed production, including but not limited to Brassica napus, Brassica juncea, Brassica rapa, Brassica carinata.
Eukaryotic translation initiation factor 5A (eIF-5A) and/or deoxyhypusine synthase (DHS) relates to conferring useful traits, particularly increased seed yield, in plants based on modulating the gene expression.
Licensed Patents all Patents a) owned by Licensor and b) licensed-in, with the right to grant sublicenses, by Licensor, which relate to the Licensed Technology, including, without limitation, those Patents listed in ANNEX I.
US 6,538,182 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
US 7,033,833 – Polynucleotides encoding carnation senescense-induced EIF-5A
US 6,900,368 – Tomato antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants
Product any and all Brassica which contains at least one Gene Component, and which would infringe at least one Valid Claim of the Licensed Patents in the absence of a license under this Agreement.
Licensed Technology methods and means to modulate expression of eIF-5A and/or DHS (including all of their isoforms).
IPSCIO Record ID: 367332
US 6,538,182 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
US 6,878,860 – DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
US 7,033,833 – Polynucleotides encoding carnation senescense-induced EIF-5A
IPSCIO Record ID: 28343
Technology License for Commercialization of Licensee Products. Subject to the terms and conditions of this Agreement, Licensor grants to Licensee, an exclusive, even as to Licensor, worldwide license, with the right to sublicense (i) the Sequana Technology, and (ii) Licensor's interest in the Joint Results and Joint Patents, to make, have made and use Compounds, and to make, have made, use and sell Licensee Products, including all activities necessary to discover and develop Compounds and Licensee Products.
Right of First Refusal for Commercialization of Licensor Products. Licensor hereby grants to Licensee a Right of First Refusal to acquire an exclusive, world wide license with the right to grant sublicenses (i) the Licensor Technology and (ii) Licensor's interest in the Joint Results and the Joint Patents to make, have made, use and sell Licensor Products.
'Asthma Gene' means a Gene that during the Research Term.
'BI Products' means any pharmaceutical composition of a Compound for the treatment or prevention of Asthma in humans or animals which is covered by a BI Patent, Sequana Patent or Joint Patent. BI Products include Type I Products, Type 2a Products, Type 2b Products, Type 3 Products and Type 4 Products, which correspond, in each case, to the applicable Compound.
Specific goals of the Research will be the identification of the Gene or Genes associated with Asthma, including analysis of genetic linkage, physical mapping, sequencing and identification of mutations in any particular Gene resulting in or associated with the pathophysiological or functional changes causing, predisposing or suppressing the development of Asthma.
